about
Laboratory diagnosis of SARSEarly Detection of Epidemic GII-4 Norovirus Strains in UK and Malawi: Role of Surveillance of Sporadic Acute Gastroenteritis in Anticipating Global EpidemicsAntibodies against Lewis antigens inhibit the binding of human norovirus GII.4 virus-like particles to saliva but not to intestinal Caco-2 cellsEcological assessment of the direct and indirect effects of routine rotavirus vaccination in Merseyside, UK using data from multiple health systems: a study protocol.Data quality of 5 years of central norovirus outbreak reporting in the European Network for food-borne viruses.Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data.Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999.Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review.Campylobacter infection in children in Malawi is common and is frequently associated with enteric virus co-infectionsMolecular epidemiology of rotavirus in cats in the United Kingdom.Determination of a Viral Load Threshold To Distinguish Symptomatic versus Asymptomatic Rotavirus Infection in a High-Disease-Burden African Population.Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant.Age-Specific Incidence Rates for Norovirus in the Community and Presenting to Primary Healthcare Facilities in the United Kingdom.Molecular characterization of G11P[25] and G3P[3] human rotavirus strains associated with asymptomatic infection in South India.Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006.Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006.Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection.Rotavirus shedding in symptomatic and asymptomatic children using reverse transcription-quantitative PCR.Characterization of a Novel Conformational GII.4 Norovirus Epitope: Implications for Norovirus-Host Interactions.Rotaviruses and rotavirus vaccines.Rotavirus burden among children in the newly independent states of the former union of soviet socialist republics: literature review and first-year results from the rotavirus surveillance network.Re-assessing the total burden of norovirus circulating in the United Kingdom populationIdentification of G8 rotavirus strains determined as G12 by rotavirus genotyping PCR: updating the current genotyping methods.Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996).Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.Foodborne viral infections.Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland.Rotavirus G and P genotypes in rural Ghana.Rotavirus gastroenteritis and central nervous system (CNS) infection: characterization of the VP7 and VP4 genes of rotavirus strains isolated from paired fecal and cerebrospinal fluid samples from a child with CNS diseaseEvidence for genetic linkage between the gene segments encoding NSP4 and VP6 proteins in common and reassortant human rotavirus strains.Evidence of intrafamilial transmission of rotavirus in a birth cohort in South India.Anti-VP6 IgG antibodies against group A and group C rotaviruses in South India.Group A Rotaviruses circulating prior to a National Immunization Programme in Nigeria: clinical manifestations, high G12P[8] frequency, intra-genotypic divergence of VP4 and VP7.Quantitation of group A rotavirus by real-time reverse-transcription-polymerase chain reaction: correlation with clinical severity in children in South India.Emergence and spread of G3P[8] rotaviruses possessing an equine-like VP7 and a DS-1-like genetic backbone in the Basque Country (North of Spain), 2015.Whole-genome characterisation of G12P[6] rotavirus strains possessing two distinct genotype constellations co-circulating in Blantyre, Malawi, 2008.Human caliciviruses in symptomatic and asymptomatic infections in children in Vellore, South India.Early impact of rotavirus vaccination in a large paediatric hospital in the UK.Diversity of group A rotavirus on a UK pig farm.Increased detection of G3P[9] and G6P[9] rotavirus strains in hospitalized children with acute diarrhea in Bulgaria.
P50
Q24675259-F329C56D-9CD8-4E82-8643-2BAFF8B658C7Q30387327-131263E3-7A91-4A7C-82E8-D59AE0C0B1D2Q30388370-D64E19E3-5EA3-40CF-A6E5-CA815BACD31FQ30872011-778F3934-3A75-44C3-8756-9381B86D9907Q31140396-C7E6AA01-9BAF-4756-84A9-5D88D60D31D3Q33509875-03DF103A-3591-447C-89C8-E08250BB5A4DQ33851207-AC4C2763-3520-4B42-AE87-27BDEE3A2C57Q34374858-37981D42-19B2-408A-8FE2-1C832DC96CDCQ34651824-F9B963F1-30E4-48AA-987D-A6E405205394Q34983177-2024007F-FFC1-484B-9A09-49685164B54AQ35607488-5C42CB07-D125-4040-910D-BAE4E05AC8DBQ35682819-97E00FB7-0671-43A1-A6CD-4077BB0D3CBEQ36440199-9D2A4C39-6EE2-410E-9597-14B8D4C5A4CEQ36769311-EC9155B9-D611-4266-A364-AA8139B44E92Q36898234-FD0B387B-C391-48D3-B3C7-D6C09D61B638Q36933517-501C05DF-C8EB-4404-B566-72C85B940418Q37123967-58B9CFE6-C23D-4541-B794-EC2B8DA6C3E2Q37136707-7663342B-B335-4FAA-94D8-692E7EBC7BFBQ37182665-F2D9BA22-C8E5-466B-8CEA-121BD40AB75EQ37398400-8CB324EC-71A5-4230-BD99-3238B84F7A1FQ37611833-70ECABC8-5D44-4FEA-9BED-CF15193BDD83Q37619107-81F91783-0D5C-408B-AF7C-64D46ED9D244Q38346630-E603208B-03D7-41A1-A748-1E58FBF04B2CQ38432846-7AC4BC45-46B2-4D61-A507-1F7AB8DAD2B8Q38623481-493F549E-D1DC-4516-B78C-29E1030E8629Q38907571-D0F4073F-5C24-40AA-953E-6958A22923D0Q39162563-DC3D8C35-BF4D-4069-905B-3B4577BD6615Q39464736-27A4A346-AABB-49A3-926A-66D3476C29E0Q39750950-7D389005-BF7D-456B-8F0D-E34DB6E82B25Q39848531-997343E0-D52C-43F2-83E0-4FC166A1141DQ39857792-036AB022-8DCD-454B-B16B-3C6B01C5D00CQ39898972-46FB2946-42D2-4D99-B152-F995EC668069Q40041680-FB1F49F1-C2DE-45F8-896C-A54D4E489CACQ40085998-F666230A-5EE8-4EE2-A486-46475ED3F9B3Q40386445-D401E8FE-AECE-49F3-978C-7FCDC90CF79FQ40513243-2EA384A7-DFC4-473B-AE3D-7C13EB4609AEQ40569793-36799B6E-81EE-47AF-8743-B6F137D05B9CQ40791513-AB238406-C310-4299-8C89-2BAF93CF9D02Q40968294-F3CE0655-C5CE-45B5-819E-B5F1A2CDFA11Q41626088-0AE4AF7A-9AC5-4930-988B-396AF85CEDC8
P50
description
Forscher
@de
chercheur
@fr
hulumtuese
@sq
investigador
@es
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
研究者
@zh
name
M Iturriza
@nl
M Iturriza
@sl
Miren Iturriza
@en
Miren Iturriza
@es
Miren Iturriza
@ga
type
label
M Iturriza
@nl
M Iturriza
@sl
Miren Iturriza
@en
Miren Iturriza
@es
Miren Iturriza
@ga
altLabel
M Iturriza
@en
prefLabel
M Iturriza
@nl
M Iturriza
@sl
Miren Iturriza
@en
Miren Iturriza
@es
Miren Iturriza
@ga
P108
P1153
55663205600
P21
P27
P31
P496
0000-0001-5816-6423